Reactions 1704, p153 - 2 Jun 2018 Various toxicities: 4 case reports In a retrospective study of 24 patients, four patients [ages and sexes not stated] were described who developed haematological toxicity, ulcer, gastric haemorrhage or duodenal stenosis following treatment with gemcitabine and erlotinib [routes, durations of treatments to reactions onsets and outcomes not stated] for locally advanced pancreatic cancer. The patients with unresectable locally advanced pancreatic cancer started receiving chemoradiotherapy (CRT) with gemcitabine 1000 mg/m on days 1, 8 and 15 and erlotinib 100 mg daily on a 4 week cycle, along with radiotherapy. The patients experienced grade 3 haematological toxicity, grade 2 ulcer, grade 3 gastric haemorrhage and grade 3 duodenal stenosis (one patient each). Author comment: "Grade 3 hematologic toxicity was observed in . . . 1 patient during CRT." "[G]rade 2 ulcer developed in 1 patient". "Grade 3 gastric hemorrhage was observed in 1 patient who received 50.4 Gy and grade 3 duodenal stenosis in 1 patient who received 55.8 Gy." Kim E, et al. Chemoradiotherapy after gemcitabine plus erlotinib in patients with locally advanced pancreatic cancer. Journal of B. U. ON: Official Journal of the Balkan Union of Oncology 22: 1046-1052, No. 4, Jul-Aug 2017. Available from: URL: https://jbuon.com/volume-22-issue-4-july-august-2017/ - South Korea 803323849 0114-9954/18/1704-0001/$14.95 Adis © 2018 Springer International Publishing AG. All rights reserved Reactions 2 Jun 2018 No. 1704
Reactions Weekly – Springer Journals
Published: Jun 2, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera